{
  "id": "https://openalex.org/W2123204151",
  "doi": "https://doi.org/10.1200/jco.2013.51.5098",
  "title": "How to Incorporate New Tyrosine Kinase Inhibitors in the Treatment of Patients With Medullary Thyroid Cancer",
  "display_name": "How to Incorporate New Tyrosine Kinase Inhibitors in the Treatment of Patients With Medullary Thyroid Cancer",
  "publication_year": 2013,
  "publication_date": "2013-09-04",
  "ids": {
    "openalex": "https://openalex.org/W2123204151",
    "doi": "https://doi.org/10.1200/jco.2013.51.5098",
    "mag": "2123204151",
    "pmid": "https://pubmed.ncbi.nlm.nih.gov/24002516"
  },
  "language": "en",
  "primary_location": {
    "is_oa": true,
    "landing_page_url": "https://doi.org/10.1200/jco.2013.51.5098",
    "pdf_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.51.5098",
    "source": {
      "id": "https://openalex.org/S15137598",
      "display_name": "Journal of Clinical Oncology",
      "issn_l": "0732-183X",
      "issn": [
        "0732-183X",
        "1527-7755"
      ],
      "is_oa": false,
      "is_in_doaj": false,
      "is_indexed_in_scopus": true,
      "is_core": true,
      "host_organization": "https://openalex.org/P4310315671",
      "host_organization_name": "Lippincott Williams & Wilkins",
      "host_organization_lineage": [
        "https://openalex.org/P4310315671",
        "https://openalex.org/P4310318547"
      ],
      "host_organization_lineage_names": [
        "Lippincott Williams & Wilkins",
        "Wolters Kluwer"
      ],
      "type": "journal"
    },
    "license": null,
    "license_id": null,
    "version": "publishedVersion",
    "is_accepted": true,
    "is_published": true
  },
  "type": "letter",
  "type_crossref": "journal-article",
  "indexed_in": [
    "crossref",
    "pubmed"
  ],
  "open_access": {
    "is_oa": true,
    "oa_status": "bronze",
    "oa_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.51.5098",
    "any_repository_has_fulltext": false
  },
  "authorships": [
    {
      "author_position": "first",
      "author": {
        "id": "https://openalex.org/A5080875822",
        "display_name": "Robert I. Haddad",
        "orcid": "https://orcid.org/0000-0003-1413-0079"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "ror": "https://ror.org/04b6nzv94",
          "country_code": "US",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1283280774",
            "https://openalex.org/I48633490"
          ]
        },
        {
          "id": "https://openalex.org/I136199984",
          "display_name": "Harvard University",
          "ror": "https://ror.org/03vek6s52",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I136199984"
          ]
        },
        {
          "id": "https://openalex.org/I4210161994",
          "display_name": "Dana-Farber Brigham Cancer Center",
          "ror": "https://ror.org/05rgrbr06",
          "country_code": "US",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I1283280774",
            "https://openalex.org/I4210117453",
            "https://openalex.org/I4210161994",
            "https://openalex.org/I48633490"
          ]
        },
        {
          "id": "https://openalex.org/I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "ror": "https://ror.org/02jzgtq86",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I4210117453"
          ]
        }
      ],
      "countries": [
        "US"
      ],
      "is_corresponding": true,
      "raw_author_name": "Robert I. Haddad",
      "raw_affiliation_strings": [
        "Dana-Farber Cancer Institute, Harvard Medical School; and Brigham and Women's Hospital, Boston, MA"
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "Dana-Farber Cancer Institute, Harvard Medical School; and Brigham and Women's Hospital, Boston, MA",
          "institution_ids": [
            "https://openalex.org/I1283280774",
            "https://openalex.org/I136199984",
            "https://openalex.org/I4210161994",
            "https://openalex.org/I4210117453"
          ]
        }
      ]
    }
  ],
  "institution_assertions": [],
  "countries_distinct_count": 1,
  "institutions_distinct_count": 4,
  "corresponding_author_ids": [
    "https://openalex.org/A5080875822"
  ],
  "corresponding_institution_ids": [
    "https://openalex.org/I1283280774",
    "https://openalex.org/I136199984",
    "https://openalex.org/I4210161994",
    "https://openalex.org/I4210117453"
  ],
  "apc_list": null,
  "apc_paid": null,
  "fwci": null,
  "has_fulltext": true,
  "fulltext_origin": "ngrams",
  "cited_by_count": 15,
  "citation_normalized_percentile": {
    "value": 0.775553,
    "is_in_top_1_percent": false,
    "is_in_top_10_percent": false
  },
  "cited_by_percentile_year": {
    "min": 88,
    "max": 89
  },
  "biblio": {
    "volume": "31",
    "issue": "29",
    "first_page": "3618",
    "last_page": "3620"
  },
  "is_retracted": false,
  "is_paratext": false,
  "primary_topic": {
    "id": "https://openalex.org/T10329",
    "display_name": "Thyroid Cancer Diagnosis and Treatment",
    "score": 0.9997,
    "subfield": {
      "id": "https://openalex.org/subfields/2712",
      "display_name": "Endocrinology, Diabetes and Metabolism"
    },
    "field": {
      "id": "https://openalex.org/fields/27",
      "display_name": "Medicine"
    },
    "domain": {
      "id": "https://openalex.org/domains/4",
      "display_name": "Health Sciences"
    }
  },
  "topics": [
    {
      "id": "https://openalex.org/T10329",
      "display_name": "Thyroid Cancer Diagnosis and Treatment",
      "score": 0.9997,
      "subfield": {
        "id": "https://openalex.org/subfields/2712",
        "display_name": "Endocrinology, Diabetes and Metabolism"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T10754",
      "display_name": "Neuroendocrine Tumor Research Advances",
      "score": 0.9423,
      "subfield": {
        "id": "https://openalex.org/subfields/2713",
        "display_name": "Epidemiology"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    }
  ],
  "keywords": [
    {
      "id": "https://openalex.org/keywords/medullary-thyroid-cancer",
      "display_name": "Medullary Thyroid Cancer",
      "score": 0.6534155
    }
  ],
  "concepts": [
    {
      "id": "https://openalex.org/C71924100",
      "wikidata": "https://www.wikidata.org/wiki/Q11190",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.90512407
    },
    {
      "id": "https://openalex.org/C2780120053",
      "wikidata": "https://www.wikidata.org/wiki/Q3493538",
      "display_name": "Medullary thyroid cancer",
      "level": 4,
      "score": 0.6534155
    },
    {
      "id": "https://openalex.org/C42362537",
      "wikidata": "https://www.wikidata.org/wiki/Q87099740",
      "display_name": "Tyrosine kinase",
      "level": 3,
      "score": 0.6448688
    },
    {
      "id": "https://openalex.org/C2779761222",
      "wikidata": "https://www.wikidata.org/wiki/Q826522",
      "display_name": "Thyroid cancer",
      "level": 3,
      "score": 0.5786961
    },
    {
      "id": "https://openalex.org/C121608353",
      "wikidata": "https://www.wikidata.org/wiki/Q12078",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.51572615
    },
    {
      "id": "https://openalex.org/C502942594",
      "wikidata": "https://www.wikidata.org/wiki/Q3421914",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.4898512
    },
    {
      "id": "https://openalex.org/C143998085",
      "wikidata": "https://www.wikidata.org/wiki/Q162555",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.46022043
    },
    {
      "id": "https://openalex.org/C126322002",
      "wikidata": "https://www.wikidata.org/wiki/Q11180",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.44650957
    },
    {
      "id": "https://openalex.org/C526584372",
      "wikidata": "https://www.wikidata.org/wiki/Q16399",
      "display_name": "Thyroid",
      "level": 2,
      "score": 0.4390027
    },
    {
      "id": "https://openalex.org/C170493617",
      "wikidata": "https://www.wikidata.org/wiki/Q208467",
      "display_name": "Receptor",
      "level": 2,
      "score": 0.15479785
    }
  ],
  "mesh": [
    {
      "descriptor_ui": "D000813",
      "descriptor_name": "Anilides",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D047428",
      "descriptor_name": "Protein Kinase Inhibitors",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D011725",
      "descriptor_name": "Pyridines",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D013964",
      "descriptor_name": "Thyroid Neoplasms",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D000813",
      "descriptor_name": "Anilides",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D018278",
      "descriptor_name": "Carcinoma, Neuroendocrine",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D005260",
      "descriptor_name": "Female",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006801",
      "descriptor_name": "Humans",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D008297",
      "descriptor_name": "Male",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D047428",
      "descriptor_name": "Protein Kinase Inhibitors",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011725",
      "descriptor_name": "Pyridines",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D013964",
      "descriptor_name": "Thyroid Neoplasms",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    }
  ],
  "locations_count": 2,
  "locations": [
    {
      "is_oa": true,
      "landing_page_url": "https://doi.org/10.1200/jco.2013.51.5098",
      "pdf_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.51.5098",
      "source": {
        "id": "https://openalex.org/S15137598",
        "display_name": "Journal of Clinical Oncology",
        "issn_l": "0732-183X",
        "issn": [
          "0732-183X",
          "1527-7755"
        ],
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": true,
        "is_core": true,
        "host_organization": "https://openalex.org/P4310315671",
        "host_organization_name": "Lippincott Williams & Wilkins",
        "host_organization_lineage": [
          "https://openalex.org/P4310315671",
          "https://openalex.org/P4310318547"
        ],
        "host_organization_lineage_names": [
          "Lippincott Williams & Wilkins",
          "Wolters Kluwer"
        ],
        "type": "journal"
      },
      "license": null,
      "license_id": null,
      "version": "publishedVersion",
      "is_accepted": true,
      "is_published": true
    },
    {
      "is_oa": false,
      "landing_page_url": "https://pubmed.ncbi.nlm.nih.gov/24002516",
      "pdf_url": null,
      "source": {
        "id": "https://openalex.org/S4306525036",
        "display_name": "PubMed",
        "issn_l": null,
        "issn": null,
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": false,
        "is_core": false,
        "host_organization": "https://openalex.org/I1299303238",
        "host_organization_name": "National Institutes of Health",
        "host_organization_lineage": [
          "https://openalex.org/I1299303238"
        ],
        "host_organization_lineage_names": [
          "National Institutes of Health"
        ],
        "type": "repository"
      },
      "license": null,
      "license_id": null,
      "version": null,
      "is_accepted": false,
      "is_published": false
    }
  ],
  "best_oa_location": {
    "is_oa": true,
    "landing_page_url": "https://doi.org/10.1200/jco.2013.51.5098",
    "pdf_url": "https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.51.5098",
    "source": {
      "id": "https://openalex.org/S15137598",
      "display_name": "Journal of Clinical Oncology",
      "issn_l": "0732-183X",
      "issn": [
        "0732-183X",
        "1527-7755"
      ],
      "is_oa": false,
      "is_in_doaj": false,
      "is_indexed_in_scopus": true,
      "is_core": true,
      "host_organization": "https://openalex.org/P4310315671",
      "host_organization_name": "Lippincott Williams & Wilkins",
      "host_organization_lineage": [
        "https://openalex.org/P4310315671",
        "https://openalex.org/P4310318547"
      ],
      "host_organization_lineage_names": [
        "Lippincott Williams & Wilkins",
        "Wolters Kluwer"
      ],
      "type": "journal"
    },
    "license": null,
    "license_id": null,
    "version": "publishedVersion",
    "is_accepted": true,
    "is_published": true
  },
  "sustainable_development_goals": [
    {
      "display_name": "Good health and well-being",
      "id": "https://metadata.un.org/sdg/3",
      "score": 0.68
    }
  ],
  "grants": [],
  "datasets": [],
  "versions": [],
  "referenced_works_count": 9,
  "referenced_works": [
    "https://openalex.org/W2101005605",
    "https://openalex.org/W2119501407",
    "https://openalex.org/W2122956665",
    "https://openalex.org/W2136146667",
    "https://openalex.org/W2146044942",
    "https://openalex.org/W2158011521",
    "https://openalex.org/W2244113487",
    "https://openalex.org/W2943433104",
    "https://openalex.org/W2965138349"
  ],
  "related_works": [
    "https://openalex.org/W44938027",
    "https://openalex.org/W4211213741",
    "https://openalex.org/W3048724254",
    "https://openalex.org/W2746560743",
    "https://openalex.org/W2531120386",
    "https://openalex.org/W2530895752",
    "https://openalex.org/W2137822387",
    "https://openalex.org/W2068822820",
    "https://openalex.org/W2046572122",
    "https://openalex.org/W1974988242"
  ],
  "abstract_inverted_index": {
    "Medullary": [
      0,
      243
    ],
    "thyroid": [
      1,
      15,
      26
    ],
    "cancer": [
      2,
      48
    ],
    "(MTC),": [
      3
    ],
    "a": [
      4,
      46,
      51,
      260,
      273,
      287,
      345,
      356,
      454,
      611,
      635,
      649,
      681
    ],
    "neuroendocrine": [
      5
    ],
    "tumor": [
      6,
      752
    ],
    "arising": [
      7
    ],
    "from": [
      8
    ],
    "the": [
      9,
      14,
      166,
      188,
      206,
      219,
      229,
      233,
      236,
      250,
      323,
      364,
      399,
      415,
      418,
      427,
      439,
      460,
      471,
      501,
      551,
      571,
      593,
      602,
      687,
      690,
      699,
      721,
      746
    ],
    "parafollicular": [
      10
    ],
    "C": [
      11
    ],
    "cells": [
      12
    ],
    "of": [
      13,
      24,
      30,
      32,
      40,
      45,
      162,
      190,
      235,
      238,
      348,
      359,
      417,
      424,
      456,
      467,
      488,
      497,
      524,
      530,
      534,
      539,
      542,
      577,
      604,
      658,
      709,
      711
    ],
    "gland,": [
      16
    ],
    "is": [
      17,
      43,
      546,
      565,
      590,
      610,
      634,
      665,
      734,
      743
    ],
    "rare": [
      18
    ],
    "and": [
      19,
      36,
      78,
      86,
      97,
      121,
      128,
      137,
      146,
      169,
      181,
      222,
      302,
      316,
      344,
      391,
      406,
      435,
      481,
      554,
      575,
      631,
      675,
      741,
      755
    ],
    "accounts": [
      20
    ],
    "for": [
      21,
      109,
      154,
      187,
      228,
      379,
      384,
      433,
      438,
      503,
      715,
      720,
      745
    ],
    "approximately": [
      22
    ],
    "5%": [
      23
    ],
    "all": [
      25
    ],
    "cancers.": [
      27
    ],
    "The": [
      28,
      256,
      294,
      353,
      421,
      441,
      528,
      586,
      661,
      702
    ],
    "majority": [
      29
    ],
    "cases": [
      31
    ],
    "MTC": [
      33,
      42,
      132
    ],
    "are": [
      34,
      73,
      82,
      87,
      100,
      118,
      122,
      670
    ],
    "sporadic,": [
      35
    ],
    "in": [
      37,
      160,
      209,
      241,
      249,
      266,
      272,
      426,
      459,
      470,
      484,
      592,
      606,
      622,
      651
    ],
    "roughly": [
      38
    ],
    "25%": [
      39
    ],
    "cases,": [
      41
    ],
    "part": [
      44
    ],
    "hereditary": [
      47
    ],
    "syndrome": [
      49
    ],
    "with": [
      50,
      69,
      75,
      112,
      115,
      125,
      157,
      192,
      361,
      448,
      500,
      648,
      654,
      762
    ],
    "well-characterized": [
      52
    ],
    "germline": [
      53
    ],
    "RET": [
      54
    ],
    "mutation:": [
      55
    ],
    "multiple": [
      56,
      60
    ],
    "endocrine": [
      57,
      61
    ],
    "neoplasia": [
      58,
      62
    ],
    "2A,": [
      59
    ],
    "(MEN)": [
      63
    ],
    "2B,": [
      64
    ],
    "or": [
      65,
      106,
      194,
      198,
      286,
      506
    ],
    "familial": [
      66
    ],
    "MTC.": [
      67,
      113,
      200,
      608,
      660
    ],
    "Patients": [
      68,
      114,
      318
    ],
    "newly": [
      70
    ],
    "diagnosed": [
      71
    ],
    "disease": [
      72,
      117,
      159,
      292,
      332,
      341,
      388
    ],
    "treated": [
      74
    ],
    "surgery.": [
      76,
      94
    ],
    "Calcitonin": [
      77
    ],
    "carcinoembryonic": [
      79
    ],
    "antigen": [
      80
    ],
    "(CEA)": [
      81
    ],
    "useful": [
      83,
      107
    ],
    "blood": [
      84
    ],
    "markers": [
      85
    ],
    "often": [
      88,
      123
    ],
    "used": [
      89,
      680
    ],
    "to": [
      90,
      103,
      139,
      276,
      329,
      338,
      372,
      401,
      404,
      567,
      600,
      698,
      729
    ],
    "monitor": [
      91
    ],
    "patients": [
      92,
      111,
      156,
      191,
      268,
      397,
      447,
      489,
      493,
      513,
      653
    ],
    "after": [
      93
    ],
    "Systemic": [
      95
    ],
    "chemotherapy": [
      96
    ],
    "radiation": [
      98
    ],
    "therapy": [
      99,
      141
    ],
    "not": [
      101,
      119,
      327,
      412,
      694
    ],
    "believed": [
      102
    ],
    "represent": [
      104
    ],
    "important": [
      105,
      620
    ],
    "options": [
      108,
      152
    ],
    "most": [
      110
    ],
    "metastatic": [
      116,
      158,
      199,
      659
    ],
    "curable": [
      120
    ],
    "monitored": [
      124
    ],
    "serial": [
      126
    ],
    "scans": [
      127
    ],
    "biochemical": [
      129,
      313,
      392,
      756
    ],
    "markers.": [
      130
    ],
    "Metastatic": [
      131
    ],
    "can": [
      133
    ],
    "be": [
      134
    ],
    "quite": [
      135
    ],
    "indolent,": [
      136
    ],
    "timing": [
      138
    ],
    "initiate": [
      140
    ],
    "varies": [
      142
    ],
    "greatly": [
      143
    ],
    "among": [
      144
    ],
    "physicians": [
      145
    ],
    "practices.": [
      147
    ],
    "Until": [
      148
    ],
    "recently,": [
      149
    ],
    "no": [
      150,
      522,
      735
    ],
    "satisfactory": [
      151
    ],
    "existed": [
      153
    ],
    "treating": [
      155
    ],
    "need": [
      161
    ],
    "therapy.": [
      163,
      585
    ],
    "In": [
      164,
      217
    ],
    "2011,": [
      165
    ],
    "US": [
      167,
      220,
      552
    ],
    "Food": [
      168,
      221,
      553
    ],
    "Drug": [
      170,
      223,
      555
    ],
    "Administration": [
      171,
      224,
      556
    ],
    "approved": [
      172,
      226
    ],
    "vandetanib": [
      173,
      279,
      362,
      380,
      434,
      472,
      498,
      545,
      584
    ],
    "(which": [
      174
    ],
    "targets": [
      175,
      617
    ],
    "RET,": [
      176
    ],
    "epidermal": [
      177
    ],
    "growth": [
      178,
      184,
      627
    ],
    "factor": [
      179,
      185,
      628
    ],
    "receptor,": [
      180
    ],
    "vascular": [
      182,
      625
    ],
    "endothelial": [
      183,
      626
    ],
    "receptor)": [
      186
    ],
    "treatment": [
      189,
      425,
      531
    ],
    "symptomatic": [
      193
    ],
    "progressive,": [
      195
    ],
    "locally": [
      196
    ],
    "advanced,": [
      197
    ],
    "This": [
      201,
      394,
      563,
      677
    ],
    "approval": [
      202
    ],
    "was": [
      203,
      259,
      298,
      411,
      430,
      536
    ],
    "based": [
      204
    ],
    "on": [
      205,
      232
    ],
    "Zactima": [
      207
    ],
    "Efficacy": [
      208,
      237
    ],
    "Thyroid": [
      210,
      244
    ],
    "Cancer": [
      211,
      245
    ],
    "Assessment": [
      212
    ],
    "(ZETA)": [
      213
    ],
    "phase": [
      214,
      263,
      429,
      637
    ],
    "III": [
      215,
      264,
      638
    ],
    "study.": [
      216
    ],
    "2012,": [
      218
    ],
    "also": [
      225,
      382,
      679,
      759
    ],
    "cabozantinib": [
      227,
      605,
      642,
      716
    ],
    "same": [
      230
    ],
    "indication": [
      231
    ],
    "basis": [
      234
    ],
    "XL184": [
      239
    ],
    "(Cabozantinib)": [
      240
    ],
    "Advanced": [
      242
    ],
    "(EXAM)": [
      246
    ],
    "trial": [
      247,
      265,
      325,
      443,
      639
    ],
    "reported": [
      248,
      591
    ],
    "article": [
      251,
      594
    ],
    "that": [
      252,
      589,
      595,
      616
    ],
    "accompanies": [
      253,
      596
    ],
    "this": [
      254,
      540,
      597
    ],
    "editorial.": [
      255
    ],
    "ZETA": [
      257,
      324,
      442,
      688
    ],
    "study": [
      258,
      354,
      395,
      588,
      678,
      692,
      703
    ],
    "randomized": [
      261,
      428
    ],
    "double-blind": [
      262,
      636
    ],
    "which": [
      267
    ],
    "were": [
      269,
      307,
      320,
      326,
      336,
      381,
      521,
      758
    ],
    "randomly": [
      270
    ],
    "assigned": [
      271
    ],
    "2:1": [
      274,
      682
    ],
    "fashion": [
      275
    ],
    "receive": [
      277
    ],
    "oral": [
      278,
      641
    ],
    "300": [
      280
    ],
    "mg": [
      281,
      645
    ],
    "per": [
      282,
      646
    ],
    "day": [
      283,
      647
    ],
    "(n": [
      284,
      289
    ],
    "231)": [
      285
    ],
    "placebo": [
      288,
      365,
      400,
      461,
      502,
      650,
      722
    ],
    "100)": [
      290
    ],
    "until": [
      291
    ],
    "progression.": [
      293
    ],
    "primary": [
      295,
      662,
      706
    ],
    "end": [
      296,
      305,
      663,
      668,
      707,
      749
    ],
    "point": [
      297,
      664,
      708
    ],
    "progression-free": [
      299
    ],
    "survival": [
      300,
      409,
      736,
      748
    ],
    "(PFS),": [
      301
    ],
    "relevant": [
      303
    ],
    "secondary": [
      304
    ],
    "points": [
      306,
      669
    ],
    "objective": [
      308,
      385
    ],
    "response": [
      309,
      386,
      671,
      753
    ],
    "rate,": [
      310,
      387,
      390,
      672
    ],
    "overall": [
      311,
      408,
      673,
      747
    ],
    "survival,": [
      312,
      674
    ],
    "response,": [
      314
    ],
    "safety,": [
      315
    ],
    "tolerability.": [
      317
    ],
    "who": [
      319
    ],
    "enrolled": [
      321
    ],
    "onto": [
      322
    ],
    "required": [
      328,
      337,
      494
    ],
    "have": [
      330,
      339
    ],
    "progressive": [
      331,
      607
    ],
    "before": [
      333
    ],
    "enrollment": [
      334
    ],
    "but": [
      335,
      519,
      685
    ],
    "measurable": [
      340
    ],
    "at": [
      342,
      349,
      414,
      643
    ],
    "baseline": [
      343
    ],
    "calcitonin": [
      346
    ],
    "level": [
      347
    ],
    "least": [
      350
    ],
    "500": [
      351
    ],
    "pg/mL.": [
      352
    ],
    "showed": [
      355
    ],
    "significant": [
      357,
      377
    ],
    "prolongation": [
      358,
      508,
      579,
      710
    ],
    "PFS": [
      360,
      455,
      466
    ],
    "versus": [
      363,
      717
    ],
    "(hazard": [
      366,
      723
    ],
    "ratio,": [
      367,
      724
    ],
    "0.46;": [
      368
    ],
    "95%": [
      369,
      726
    ],
    "CI,": [
      370,
      727
    ],
    "0.31": [
      371
    ],
    "0.69;": [
      373
    ],
    "P": [
      374,
      731
    ],
    ".001).": [
      375,
      732
    ],
    "Statistically": [
      376
    ],
    "advantages": [
      378
    ],
    "seen": [
      383,
      413
    ],
    "control": [
      389
    ],
    "response.": [
      393
    ],
    "allowed": [
      396
    ],
    "receiving": [
      398,
      490
    ],
    "cross": [
      402,
      696
    ],
    "over": [
      403,
      697
    ],
    "vandetanib,": [
      405
    ],
    "an": [
      407,
      464
    ],
    "advantage": [
      410,
      737
    ],
    "time": [
      416
    ],
    "initial": [
      419
    ],
    "report.": [
      420
    ],
    "median": [
      422
    ],
    "duration": [
      423
    ],
    "90.1": [
      431
    ],
    "weeks": [
      432,
      437
    ],
    "39.9": [
      436
    ],
    "placebo.": [
      440
    ],
    "clearly": [
      444
    ],
    "included": [
      445
    ],
    "many": [
      446
    ],
    "indolent": [
      449
    ],
    "disease,": [
      450
    ],
    "as": [
      451,
      477
    ],
    "evidenced": [
      452
    ],
    "by": [
      453
    ],
    "19.3": [
      457
    ],
    "months": [
      458,
      469,
      714,
      719
    ],
    "group": [
      462
    ],
    "(with": [
      463
    ],
    "estimated": [
      465
    ],
    "30": [
      468
    ],
    "group).": [
      473
    ],
    "Adverse": [
      474
    ],
    "events": [
      475,
      505
    ],
    "such": [
      476
    ],
    "diarrhea,": [
      478
    ],
    "rash,": [
      479
    ],
    "nausea,": [
      480
    ],
    "hypertension": [
      482
    ],
    "occurred": [
      483
    ],
    "more": [
      485
    ],
    "than": [
      486
    ],
    "30%": [
      487
    ],
    "vandetanib.": [
      491
    ],
    "More": [
      492
    ],
    "dose": [
      495
    ],
    "reduction": [
      496
    ],
    "compared": [
      499
    ],
    "adverse": [
      504
    ],
    "QTc": [
      507,
      517
    ],
    "(35%": [
      509
    ],
    "v": [
      510
    ],
    "3%).": [
      511
    ],
    "Nineteen": [
      512
    ],
    "(8%)": [
      514
    ],
    "developed": [
      515
    ],
    "protocol-defined": [
      516
    ],
    "prolongation,": [
      518,
      544
    ],
    "there": [
      520
    ],
    "reports": [
      523
    ],
    "torsades": [
      525
    ],
    "de": [
      526
    ],
    "pointes.": [
      527
    ],
    "rate": [
      529
    ],
    "discontinuation": [
      532
    ],
    "because": [
      533
    ],
    "toxicity": [
      535
    ],
    "12%.": [
      537
    ],
    "Because": [
      538
    ],
    "risk": [
      541
    ],
    "QT": [
      543,
      578
    ],
    "currently": [
      547
    ],
    "only": [
      548
    ],
    "available": [
      549
    ],
    "through": [
      550
    ],
    "Vandetanib": [
      557
    ],
    "Risk": [
      558
    ],
    "Evaluation": [
      559
    ],
    "Mitigation": [
      560
    ],
    "Strategy": [
      561
    ],
    "Program.": [
      562
    ],
    "program": [
      564
    ],
    "meant": [
      566
    ],
    "educate": [
      568
    ],
    "practitioners": [
      569
    ],
    "about": [
      570
    ],
    "risk,": [
      572
    ],
    "appropriate": [
      573
    ],
    "monitoring,": [
      574
    ],
    "management": [
      576
    ],
    "should": [
      580
    ],
    "it": [
      581
    ],
    "occur": [
      582
    ],
    "during": [
      583
    ],
    "EXAM": [
      587,
      633,
      691
    ],
    "editorial": [
      598
    ],
    "sought": [
      599
    ],
    "examine": [
      601
    ],
    "effect": [
      603
    ],
    "Cabozantinib": [
      609
    ],
    "tyrosine": [
      612
    ],
    "kinase": [
      613
    ],
    "inhibitor": [
      614
    ],
    "(TKI)": [
      615
    ],
    "three": [
      618
    ],
    "potentially": [
      619
    ],
    "pathways": [
      621
    ],
    "MTC:": [
      623
    ],
    "MET,": [
      624
    ],
    "receptor": [
      629
    ],
    "2,": [
      630
    ],
    "RET.": [
      632
    ],
    "comparing": [
      640
    ],
    "140": [
      644
    ],
    "330": [
      652
    ],
    "documented": [
      655
    ],
    "radiographic": [
      656
    ],
    "progression": [
      657
    ],
    "PFS.": [
      666
    ],
    "Other": [
      667
    ],
    "safety.": [
      676
    ],
    "randomization": [
      683
    ],
    "schema,": [
      684
    ],
    "unlike": [
      686
    ],
    "trial,": [
      689
    ],
    "did": [
      693
    ],
    "allow": [
      695
    ],
    "active": [
      700
    ],
    "drug.": [
      701
    ],
    "met": [
      704
    ],
    "its": [
      705
    ],
    "PFS:": [
      712
    ],
    "11.2": [
      713
    ],
    "4": [
      718
    ],
    "0.28;": [
      725
    ],
    "0.19": [
      728
    ],
    "0.4;": [
      730
    ],
    "There": [
      733
    ],
    "noted": [
      738
    ],
    "so": [
      739
    ],
    "far,": [
      740
    ],
    "analysis": [
      742
    ],
    "ongoing": [
      744
    ],
    "point.": [
      750
    ],
    "Objective": [
      751
    ],
    "rates": [
      754
    ],
    "responses": [
      757
    ],
    "significantly": [
      760
    ],
    "improved": [
      761
    ],
    "cabozantinib.": [
      763
    ],
    "JOURNAL": [
      764
    ],
    "OF": [
      765
    ],
    "CLINICAL": [
      766
    ],
    "ONCOLOGY": [
      767
    ],
    "E": [
      768
    ],
    "D": [
      769
    ],
    "I": [
      770,
      774
    ],
    "T": [
      771
    ],
    "O": [
      772
    ],
    "R": [
      773
    ],
    "A": [
      775
    ],
    "L": [
      776
    ],
    "VOLUME": [
      777
    ],
    "31": [
      778
    ],
    "NUMBER": [
      779
    ],
    "29": [
      780
    ],
    "OCTOBER": [
      781
    ],
    "1": [
      782
    ]
  },
  "abstract_inverted_index_v3": null,
  "cited_by_api_url": "https://api.openalex.org/works?filter=cites:W2123204151",
  "counts_by_year": [
    {
      "year": 2022,
      "cited_by_count": 4
    },
    {
      "year": 2019,
      "cited_by_count": 3
    },
    {
      "year": 2018,
      "cited_by_count": 1
    },
    {
      "year": 2017,
      "cited_by_count": 1
    },
    {
      "year": 2016,
      "cited_by_count": 2
    },
    {
      "year": 2014,
      "cited_by_count": 4
    }
  ],
  "updated_date": "2025-05-23T06:34:57.464363",
  "created_date": "2016-06-24"
}